Sepsis associated encephalopathy (SAE): A review

Frontiers in Bioscience

Volumn 9, Issue , 2004, Pages 1637-1641

  Green, Rebecca ^a   Scott, L Keith ^a,b   Minagar, Alireza ^b   Conrad, Steven ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Altered Mental Status; Encephalopathy; Review; Sepsis; Septic Shock; Shock

Indexed keywords

AMINO ACID; BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; NEUROTRANSMITTER; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

AEROBIC METABOLISM; BACTERIUM; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; INCIDENCE; MUSCLE TISSUE; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; REVIEW; SEPSIS; SURVIVAL; HUMAN; METABOLISM; MICROBIOLOGY;

BACTERIA (MICROORGANISMS);

AMINO ACIDS; BLOOD-BRAIN BARRIER; BRAIN DISEASES; HUMANS; INCIDENCE; NEUROTRANSMITTER AGENTS; SEPSIS;

EID: 2442653108     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1250     Document Type: Review

References (32)

1. Sprung CL, P.N. Peduzzi, C.H. Shatney, R.M. Schein, M.F. Wilson , J.N. Sheagren & J.B. Hinshaw; Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 18(8), 801-6 (1990)
2. Angus DC, W.T. Linde-Zwirble, J. Lidickerr, G. Clermont, J. Carcillo & M.R. Pinsky; Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated cost of care. Crit Care Med 29, 1303 (2001)
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20(6), 864-74 (1992)
4. Martin GS, D.M. Mannino, S. Eaton & M. Moss; The Epidemiology of Sepsis in the United States from 1979 through 2000. N Engl J Med 348(16), 1546-1554 (2003)
5. Bernard GR, J.L. Vincent, P.F. Laterre, S.P. Larosa, J.F. Dhainqut, A. Lopez-Rodriguez, J.S. Steingrub, G.E. Garber, J.D. Heltabrand, E.W. Ely & C.J. Fisher; Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344(10), 699-709 (2001)
6. Annane D, V. Sébille, C. Charpentier, P.E. Bollaert, B. Francois, J.M. Korach, G. Capellier, Y. Chhen, E. Azoulay, G. Troche, P. Chaumet-Riffaunt & E. Bellissant; Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288, 862-871 (2002)
7. Van den Berghe G, P. Wouters, F. Weckers, C. Verwaust, F. Brugninckx, M. Schetz, D. Vlasselaers, P. Ferdinande, P. Louwers & R. Bouillon; Intensive insulin therapy in critically ill patients. N Engl J Med 345, 1359-67 (2001)
8. Rivers E, B. Nguyen, S. Havstad, J. Ressler & A. Muzzin; Early goal-directed therapy in the treatment if severe sepsis and septic shock. N Engl J Med 345, 1368 (2001)
9. Busund R, V. Koukline, U. Utrobin & E. Nedashkovsky; Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Inten Care Med (2002)
10. Sprung CL, P.N. Peduzzi, C.H. Shatney, R.M.H. Schein, M.F. Wilson, J.N. Sheagren & J.B. Hinshaw; Impact of encephalopathy on mortality in the sepsis syndrome. Crit Care Med 18, 801 (1990)
11. Basler T, A. Meier-Hellmann, D. Bredle & K. Reinhart; Amino acid imbalance early in septic encephalopathy. Intensive Care Med 23(3), 293-8 (2002)
12. Jackson AC, J.J. Gilbert, G.B. Young & C.F. Bolton; The Encephalopathy of Sepsis. Canadian Journal of Neurological Sciences 12(4), 303-307 (1985)
13. Kadoi Y, S. Saito, F. Kunimoto, T. Imai & T. Fujita; Impairment of the brain beta-adrenergic system during endotoxemia. Journal of Surgical Research 61(2), 496-502 (1996)
14. . Hasselgran PO & J.E. Fischer; Septic encephalopathy, Etiology and management. Inten Care Med 12(1), 13-6 (1986)
15. . Jeppsson B, H.R. Freund, Z. Gimmon, J.H. James, M.F. von Meyenfeldt & J.E. Fisher; Blood-brain barrier derangement in sepsis: cause of septic encephalopathy?. American Journal of Surgery 141(1), 136-142 (1981)
16. Basler T, A. Meier-Hellmann, D. Bredle & K. Reinhart; Amino acid imbalance early in septic encephalopathy. Inten Care Med 28(3), 293-8 (2002)
17. Sprung CL, F.B. Cerra, H.R. Freund, R.M. Schein, F.N. Konstantinides, E.H. Marcial & M. Pena; Amino acid alterations and encephalopathy in the sepsis syndrome. Crit Care Med 19(6), 753-757 (1991)
18. Freund HR, S. Atamian, J. Holroyde & J.E. Fisher; Plasma amino acids as predictors of the severity and outcome of sepsis. Annuals of Surgery 190, 571-576 (1979)
19. von Meyenfeldt MF, P.B. Soeters, J.P. Vente, C.L. van Berlo, M.M. Rouflart, K.P. de tong, C.J. vander Linden & D.J. Gouma; Effect of branched chain amino acid enrichment of total parenteral nutrition on nitrogen sparing and clinical outcome of sepsis and trauma: a prospective randomized double blind trial. British Journal of Surgery 77(8), 924-929 (1990)
20. Bower RH, M. Muggia-Sullam, S. Vallgran, J.M. Hurst, K.A. Kern, R. LaFrance & J.E. Fischer; Branched chain amino acid-enriched solutions in the septic patient. A randomized, prospective trial. Annals of Surgery 203(1), 13-20 (1986)
21. Mizock BA, H.C. Sabelli, A. Dubin, J.I. Javid, A. Poulos & E.C. Rachow; Septic Encephalopathy: Evidence for Altered Phenylalanine Metabolism and Comparison with Hepatic Encephalopathy. Arch Intern Med 150, 443-447 (1990)
22. Freund HR, M. Muggia-Sullam, J. Peiser & E. Melamed; Brain neurotransmitter profile is deranged during sepsis and septic encephalopathy in the rat. Journal of Surgical Research 38(3), 267-271 (1985)
23. Freund RR, M. Muggia-Sullam, R. LaFrance, J. Holroyde & J.E. Fischer; Regional Brain Amino Acid and Neurotransmitter Derangements during Abdominal Sepsis and Septic Encephalopathy in the Rat. Arch Surg 121, 209-212 (1986)
24. Winder TR, G.Y. Minuk, E.J. Sargeant & T.P. Seland; gamma-Aminobutyric acid (GABA) and sepsis-related encephalopathy. Canadian Journal of Neurological Sciences 15(1), 23-25 (1988)
25. Minuk GY; Gamma-aminobutyric acid (GABA) production by eight common bacterial pathogens. Scandinavian Journal of Infectious Diseases 18(5), 465-467 (1986)
26. Cangiano C, M.O. Farber, P. Cardelli-Cangiano, F. Rossi-Fanelli, A. Cascino, L. Capocaccia, E.M. Cockerill & F. Manfredi; Plasma levels of false neurotransmitters across the brain in portal-systemic encephalopathy. European Journal of Clinical Investigation 12(1), 15-21 (1982)
27. Nespoli A, G. Bevilacqua, C. Staudacher, N. Rossi, F. Salerno & M.R. Castelli; Pathogenesis of hepatic encephalopathy and hyperdynamic syndrome in cirrhosis. Role of false neurotransmitters. Archives of Surgery 116(9), 1129-1138 (1981)
28. Soejima Y, Y. Fujii, T. Ishikawa, H. Takeshita & T. Maekawa; Local cerebral glucose utilization in septic rats. Crit Care Med 18(4), 423-427 (1990)
29. Zhan RZ, N. Fujiwara & K. Shimoji; Regionally different elevation of intracellular free calcium in hippocampus of septic rat brain. Shock 6(4), 293-297 (1996)
30. Moller K, G.I. Strauss, J. Qvist, L. Fonsmark, G.M. Knudsen, F.S. Larsen, K.S. Krabbe, P. Skinhoj & B.K. Pederson; Cerebral blood flow and oxidative metabolism during human endotoxemia. Journal of Cerebral Blood Flow & Metabolism 22(10), 1262-1270 (2002)
31. Young GB, C.E. Bolton, Y.M. Archibald, T.W. Austin & G.A. Wells; The electroencephalogram in sepsis-associated encephalopathy. J of Clin Neurophysiol 9(1), 145-52 (1992)
32. Shilling PD & J.R. Kelsoe; Functional genomics approaches to understanding brain disorders. Pharmacogenomics. 3(1), 31-45 (2002)